What is Oaktree Acquisition Corp. III Life Sciences's (OACC) StockRank?

MoatMap's StockRank for Oaktree Acquisition Corp. III Life Sciences (OACC) is 18/100, with a Strong Sell signal. This is a composite score combining Quality (29), Value (22), and Momentum (48) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Oaktree Acquisition Corp. III Life Sciences have an economic moat?

Oaktree Acquisition Corp. III Life Sciences (OACC) has a Quality factor score of 29/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Oaktree Acquisition Corp. III Life Sciences a buy, hold, or sell?

MoatMap's current signal for Oaktree Acquisition Corp. III Life Sciences (OACC) is Strong Sell, based on a StockRank of 18/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Oaktree Acquisition Corp. III Life Sciences in?

Oaktree Acquisition Corp. III Life Sciences (OACC) operates in the Financial Services sector, specifically the Shell Companies industry (United States).

OACC

Strong SellSinker

Oaktree Acquisition Corp. III Life Sciences · Financial Services · United States · $264M · Avg Vol: $262K/d

Sinker: Weak, expensive and falling. Nothing here to keep it afloat.

StockRank

Get insider-trade alerts

Quality

Value

Momentum

P/E (TTM)

38.5x

peers 12.6x

ROE

3.7%

peers 9.6%

D/E

0.0x

peers 0.3x

Dividend %

—

trailing yield

Director trades · 180d

None →

Buybacks · 180d

None →

ABOUT OAKTREE ACQUISITION CORP. III LIFE SCIENCES

Read

Oaktree Acquisition Corp. III Life Sciences is a Special Purpose Acquisition Company (SPAC) explicitly formed to pursue a business combination with a private company in the life sciences sector. Leveraging the expertise of its sponsor, Oaktree Capital Management, the company seeks to identify and acquire a high-potential target within the biotechnology, pharmaceutical, or medical technology industries.

FINANCIAL SUMMARY (USD)

Year	2024	2025	TTM
Revenue	—	0	—
EPS	—	0.30	0.28
Shares	24.6M	24.6M	19.8M
Debt	11.8K	11.8K	11.8K
Equity	187.5M	194.8M	—
Op CF	—	-0.4M	-0.5M
Inv CF	—	0.5M	—
Fin CF	—	0	—

Loading 1Y...

PRICE (1Y)+0.3%

SMA 50SMA 200

$10.77

RSI (14)

64.0

52W High

$10.88

From 52W High

1.0%

SCORE BREAKDOWN

Quality

ROIC

-0.6%10.3

ROE

3.7%25.0

GP/Assets

—N/A

Op. Margin

0.0%14.1

FCF/Assets

—N/A

Piotroski

215.7

Int. Cover

—N/A

D/E Ratio

0.00x89.5

Current Ratio

0.73x21.6

Value

P/E (TTM)

38.5x9.1

EV/EBITDA

—N/A

P/FCF

—N/A

P/B

-35.3x25.0

P/S

—N/A

Div Yield

—N/A

Momentum

52W High %

99%95.3

RS 6M

-16%22.7

SMA 50/200

1.01x37.5

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-14%17.9

FUNDAMENTALS

Market Cap

$264M

P/E (Forward)

—

Gross Margin

—

SECTOR PEERS

Closest peers in Financial Services, ranked by industry match, size, and score similarity. Cross-listings of OACC are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
OACC	Oaktree Acquisition Corp. III Life Sciences(you)	$264M	18	Strong Sell
DMAA	Drugs Made In America Acquisition Corp.	$261M	16	Strong Sell
CUB	Lionheart Holdings	$285M	16	Strong Sell
MACI	Melar Acquisition Corp. I	$238M	19	Strong Sell
LPBB	Launch Two Acquisition Corp.	$311M	19	Strong Sell
SVCC	Stellar V Capital Corp.	$230M	19	Strong Sell
ONCH	1RT Acquisition Corp.	$223M	19	Strong Sell
MCGA	Yorkville Acquisition Corp.	$244M	15	Strong Sell
VNME	Vendome Acquisition Corporation I	$257M	22	Sell
SBXD	SilverBox Corp IV	$276M	13	Strong Sell

Peer medians: ROE 9.6% · P/E 12.6x · Gross margin 100.0%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

Oaktree Acquisition Corp. III Life Sciences (OACC): Stock Score Summary

Oaktree Acquisition Corp. III Life Sciences (OACC) has a MoatMap StockRank of 18/100 based on Quality (29/100), Value (22/100), and Momentum (48/100) factor scores. The current signal is STRONG SELL.

Key Financial Metrics

Price	$10.77
Market Cap	$264M
P/E (TTM)	38.47
Price/Book	-35.32
Return on Equity	3.7%
Return on Invested Capital	-0.6%
Debt/Equity	0.00x
Operating Margin	0.0%

Oaktree Acquisition Corp. III Life Sciences operates in the Shell Companies industry, part of the Financial Services sector (United States).

Frequently Asked Questions

What is Oaktree Acquisition Corp. III Life Sciences’s (OACC) StockRank?: MoatMap’s StockRank for Oaktree Acquisition Corp. III Life Sciences (OACC) is 18/100, with a Strong Sell signal. It is a composite of Quality (29), Value (22), and Momentum (48) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Oaktree Acquisition Corp. III Life Sciences have an economic moat?: Oaktree Acquisition Corp. III Life Sciences (OACC) has a Quality factor score of 29/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Oaktree Acquisition Corp. III Life Sciences a buy, hold, or sell?: MoatMap’s current signal for Oaktree Acquisition Corp. III Life Sciences (OACC) is Strong Sell, based on a StockRank of 18/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Oaktree Acquisition Corp. III Life Sciences in?: Oaktree Acquisition Corp. III Life Sciences (OACC) operates in the Financial Services sector, specifically the Shell Companies industry (United States).